HUMA vs DOUG
Comparison between Humacyte Inc (HUMA, Company) and Douglas Elliman Inc (DOUG, Company).
HUMA is from the Healthcare sector, while DOUG is from the Real Estate sector.
5-Year PerformanceDOUG has outperformed HUMA, delivering a return of -32.5% compared to -42.2%
HUMA vs DOUG - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
HUMA vs DOUG - Historical Returns
Returns include dividend reinvestment.
HUMA vs DOUG - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | HUMA | DOUG |
|---|---|---|
| 2026 | -25.25% | -23.25% |
| 2025 | -81.46% | +45.40% |
| 2024 | +74.74% | -42.61% |
| 2023 | +34.60% | -23.85% |
| 2022 | -71.49% | -61.06% |
| 2021 | -33.85% | -5.19% |
HUMA vs DOUG Drawdown Comparison
The maximum drawdown for HUMA was -96.62%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for DOUG was -90.25%, occurring on Jun 17, 2024. This drawdown has not yet recovered.
The current HUMA drawdown is -95.71%. The current DOUG drawdown is -83.60%.
| Rank | HUMA | DOUG |
|---|---|---|
| #1 | -96.62% Sep 1, 2021 - Mar 30, 2026 | -90.25% Dec 30, 2021 - Jun 17, 2024 |
Correlation
Correlation between HUMA and DOUG is 0.40 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks